EXTON, PA — dsm-firmenich‘s Biomedical division has announced the promotion of Robyn Wiseman to Vice President of Global Commercial, effective August 26, 2024. In her new role, Robyn will oversee the global commercial team across the Americas, EMEA, and APAC regions, steering the company’s commercial strategies in the biomedical sector.
Robyn joined dsm-firmenich in 2020 as Director of Commercial Development, where she managed several key global accounts. Her collaborative work with leading OEMs in the Orthopaedic and Cardiovascular fields quickly led to her promotion to Senior Director of Commercial Development in North America. In this capacity, Robyn successfully built and led a commercial sales team, transforming the department and driving significant revenue growth.
With over two decades of experience in the medical device industry, Robyn has worked with industry giants such as Johnson & Johnson, Abbott Vascular, and Medtronic. Her vast expertise spans Cath Lab and OR Sales, partnerships with National GPOs and IDNs, and strategic collaborations with executives in the OEM market. Before joining dsm-firmenich, Robyn served as Vice President of Global Business Development for Q Medical Devices. There, she revolutionized the sales model by developing and implementing strategies that led to global double-digit growth.
Paul Spencer, President of Biomedical, expressed confidence in Robyn’s capabilities. “We are both excited and proud to have such a strong internal candidate to take on this key position for us at Biomedical and we wish Robyn every success in her new position,” he stated. “We’re confident Robyn will continue to lead our team to new heights and help us to further establish the Biomedical division as a world leader in biomaterials.”
Robyn’s leadership and innovative approach are expected to drive further success for dsm-firmenich’s Biomedical division, solidifying its position in the global biomaterials market.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.